Search

everythinglearnresearchcommunity

for

Search:↓

LPA3 signaling in the uterus is crucial for placental formation and fetal development.

Proretinal nanoparticles are a safe and effective way to deliver retinal to the skin.

AHR ligands could treat inflammatory skin diseases.

Neuropeptides affect skin inflammation, repair, and hair growth, with potential for therapy.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Agouti protein affects melanocortin receptors through competitive antagonism and receptor down-regulation.

Blocking certain brain processes reduces mating behavior in female rats.

TRH in hair follicles can influence hair color by increasing melanin.

PrrH sRNA controls pyochelin production in *Pseudomonas aeruginosa*.

High TSPEAR levels in colorectal cancer predict worse outcomes.

A gene mutation worsens skin irritation in mice due to a lack of certain fats.

Retinoic acid changes skin cells to mucosal cells with goblet cells, needing TG2/Gh, Gbx1, and TGF-beta.

Trps1 is essential for proper hair follicle development.

CXCR2 in skin cells promotes tumor growth.

Keratin 79 is linked to liver damage and may help diagnose liver diseases.

Sex steroid receptors are found in specific skin cells, affecting skin and hair functions.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Pregnancy-related hormone changes affect Y1 receptor gene expression in mice.

A new test helps find drugs to treat head and neck cancer by targeting c-Rel.

Grasp protein helps maintain skin health after UVB exposure.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.